文 献1）Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, et al. Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017). Circ J 2019; 83: 842-945.2）Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S20-31.3）Stölting G, Fischer M, Fahlke C. CLC channel function and dysfunction in health and disease. Front Physiol 2014; 5: 378.4）Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, et al. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci U S A 2004; 101: 13861-6.5）Yamamura A, Ohara N, Tsukamoto K. Inhibition of excessive cell proliferation by calcilytics in idiopathic pulmonary arterial hypertension. PLoS One 2015; 10: e0138384.6）Verkman AS, Galietta LJ. Chloride channels as drug targets. Nat Rev Drug Discov 2009; 8: 153-71.7）Parkerson KA, Sontheimer H. Biophysical and pharmacological characterization of hypotonically activated chloride currents in cortical astrocytes. Glia 2004; 46: 419-36.8）Jentsch TJ, Pusch M. CLC chloride channels and transporters: structure, function, physiology, and disease. Physiol Rev 2018; 98: 1493-590.9）Olschewski A, Papp R, Nagaraj C, Olschewski H. Ion channels and transporters as therapeutic targets in the pulmonary circulation. Pharmacol Ther 2014; 144: 349-68.10）Tang H, Yamamura A, Yamamura H, Song S, Fraidenburg DR, Chen J, et al. Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2016; 310: L846-59.11）Smith KA, Voiriot G, Tang H, Fraidenburg DR, Song S, Yamamura H, et al. Notch activation of Ca2＋ signaling in the development of hypoxic pulmonary vasoconstriction and pulmonary hypertension. Am J Respir Cell Mol Biol 2015; 53: 355-67.12）Babicheva A, Ayon RJ, Zhao T, Ek Vitorin JF, Pohl NM, Yamamura A, et al. MicroRNA-mediated downregulation of K＋ channels in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2020; 318: L10-26.13）Yamamura A, Guo Q, Yamamura H, Zimnicka AM, Pohl NM, Smith KA, et al. Enhanced Ca2＋-sensing receptor function in idiopathic pulmonary arterial hypertension. Circ Res 2012; 111: 469-81.14）Yamamura A, Yamamura H, Zeifman A, Yuan JX. Activity of Ca2＋-activated Cl- channels contributes to regulating receptor- and store-operated Ca2＋ entry in human pulmonary artery smooth muscle cells. Pulm Circ 2011; 1: 269-79.15）Kitamura K, Yamazaki J. Chloride channels and their functional roles in smooth muscle tone in the vasculature. Jpn J Pharmacol 2001; 85: 351-7.167
元のページ ../index.html#181